HC Wainwright Issues Negative Estimate for ACAD Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – HC Wainwright dropped their Q2 2025 earnings estimates for ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, May 8th. HC Wainwright analyst A. Fein now expects that the biopharmaceutical company will post earnings of $0.11 per share for the quarter, down from […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – HC Wainwright dropped their Q2 2025 earnings estimates for ACADIA Pharmaceuticals in a research report issued to clients and investors on Thursday, May 8th. HC Wainwright analyst A. Fein now expects that the biopharmaceutical company will post earnings of $0.11 per share for the quarter, down from […]
